<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04478773</url>
  </required_header>
  <id_info>
    <org_study_id>2020-43</org_study_id>
    <nct_id>NCT04478773</nct_id>
  </id_info>
  <brief_title>Adverse Events of MRI With Abandoned Leads</brief_title>
  <official_title>Evaluating MRI Scanning in Patients With Fractured or Abandoned Endocardial Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lancaster General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lancaster General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and efficacy of MRI scanning in patients
      with fractured or abandoned endocardial leads. Specifically, the investigators aim to provide
      community-acquired data that can be used in Medicare and Medicaid coverage determinations and
      to investigate whether patients with fractured or abandoned leads can safely be scanned using
      an MRI and to evaluate the impact of MRI availability on patient care in this population.
      This study also aims to validate similar studies conducted by Mayo Clinic, the Hospital of
      the University of Pennsylvania and Johns Hopkins Medicine that employ MRI in the abandoned
      lead patient population.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Adverse Events related to Magnetic Resonance Imaging (MRI) in patients with abandoned or fractured pacemaker or implantable cardioverter defibrillator (ICD) leads</measure>
    <time_frame>2 hours</time_frame>
    <description>Determine the incidence of adverse events during MRIs in patients with abandoned or fractured leads who have a clinical need for MRI via patient questionnaire and reported observation by technologist and electrophysiology physician or advance practice provider.
Adverse events include but are not limited to:
Atrial fibrillation
Ventricular arrhythmias
Frequent premature ventricular contractions with hemodynamic instability
Symptomatic bradycardia with heart rate less than 40 beats per minute
Shortness of breath
Chest pain
Feeling of heat/pulling in the chest or device pocket</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pacemaker Electrode Lead Fracture</condition>
  <condition>ICD</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI with or without contrast</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  Patients implanted with an ICD or pacemaker with an abandoned or non-functional
             endocardial lead, and who have a clinical need for MR imaging

          -  Patients are English or Spanish speaking and able to review and sign the consent

        Exclusion:

          -  Patients who meet current Centers for Medicare &amp; Medicaid Services(CMS) approved
             indications for MRI with cardiac implanted electronic device

          -  Patients who complete the MRI standard screening form and are deemed inappropriate for
             MRI for any reason other than abandoned or fractured endocardial, or epicardial lead.

          -  Patients less than 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandeep Bansal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tawnya Vernon</last_name>
    <phone>7175447395</phone>
    <email>tawnya.vernon@pennmedicine.upenn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cath Forney</last_name>
    <phone>7175441402</phone>
    <email>Cathleen.Forney@pennmedicine.upenn.edu</email>
  </overall_contact_backup>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 13, 2020</study_first_submitted>
  <study_first_submitted_qc>July 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abandoned lead</keyword>
  <keyword>fractured lead</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 9, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT04478773/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

